Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-06-11T08:38:31.776Z Has data issue: false hasContentIssue false

Do quantitative levels of cardiac troponin I implicate on severity of disease in children, adolescences, and young adults with acute myocarditis and myopericarditis?

Published online by Cambridge University Press:  06 February 2023

Sharon Brosilow*
Affiliation:
Pediatric Cardiology & Congenital Heart Disease in Adults, The Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa, Israel Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
Wisam Abo Zaid
Affiliation:
Pediatric Cardiology & Congenital Heart Disease in Adults, The Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa, Israel Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
Daniel Maghen
Affiliation:
Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
Asaad Khoury
Affiliation:
Pediatric Cardiology & Congenital Heart Disease in Adults, The Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa, Israel Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
Doron Aharonson
Affiliation:
Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel Cardiac Intensive Care, Cardiology Unit, Rambam Health Care Campus, Haifa, Israel
Avraham Lorber
Affiliation:
Pediatric Cardiology & Congenital Heart Disease in Adults, The Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa, Israel Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
*
Author for correspondence: Sharon Brosilow, Pediatric Cardiology & Congenital Heart Disease in Adults, The Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa, Israel. E-mail: sharon.brosilow@gmail.com

Abstract

Objectives:

When cardiac muscle damage occurs, cardiac troponins are released to blood and their detection is used as a marker in clinical setting. The prognostic value of the quantitative levels of blood troponin I in cases of myocarditis and myopericarditis is unclear. The aim of this study was to analyse whether troponin quantitative blood levels can be correlated with the course of hospitalisation and prognosis.

Methods:

Retrospective data was collected from all consecutive patients aged ≤30 hospitalised with a diagnosis of acute myocarditis or acute myopericarditis in our health Care Campus between the years 2010–2016.

Results:

Ninety-three patients with myocarditis and myopericarditis were identified. Higher peak troponin levels correlated with longer hospitalisation times in the cardiac or paediatric wards (p = 0.03, Pearson correlation: r −0.23), and median troponin level at admission correlated with longer overall hospitalisation (p = 0.026, Pearson correlation: r = 0.23). Patients admitted to ICU, received oral cardiac supportive therapy or that were discharged with cardiac drugs had higher median troponin compared to patients who were not but this was not statistically significant. A small group of patients that needed intravenous cardiac support had significantly lower median peak troponin levels (n = 4, 0.375ng/ml, p = 0.048). Only two patients needed extracorporeal membrane oxygenation support, and one died. The small number of patients precludes statistical analysis.

Conclusion:

Higher troponin levels correlated significantly with longer hospitalisation, lower troponin values correlated with intravenous cardiac support, while other variables related to the severity of disease could not be significantly related to higher troponin levels.

Type
Original Article
Copyright
© The Author(s), 2023. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Neves, AL, Henriques-Coelho, T, Leite-Moreira, A, Areias, JC. Cardiac injury biomarkers in paediatric age: are we there yet? Heart Fail Rev 2016; 21: 771781.10.1007/s10741-016-9567-2CrossRefGoogle ScholarPubMed
Coudrey, L. The troponins. Arch Intern Med 1998; 158: 11731180.10.1001/archinte.158.11.1173CrossRefGoogle ScholarPubMed
Kociol, RD, Pang, PS, Gheorghiade, M, Fonarow, GC, O’Connor, CM. Felker GM Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010; 56: 10711078.10.1016/j.jacc.2010.06.016CrossRefGoogle ScholarPubMed
Wu, AH, Apple, FS, Gibler, WB, Jesse, RL, Warshaw, MM, Valdes, R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45: 11041121.10.1093/clinchem/45.7.1104CrossRefGoogle ScholarPubMed
Antman, EM, Tanasijevic, MJ, Thompson, B, et al. Braunwald E Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 13421349.10.1056/NEJM199610313351802CrossRefGoogle ScholarPubMed
Immer, FF, Stocker, F, Seiler, AM, et al. Troponin-I for prediction of early postoperative course after pediatric cardiac surgery. J Am Coll Cardiol 1999; 33: 17191723.10.1016/S0735-1097(99)00061-3CrossRefGoogle ScholarPubMed
Christenson, E, Christenson, RH. The role of cardiac biomarkers in the diagnosis and management of patients presenting with suspected acute coronary syndrome. Ann Lab. 2013; 33: 309318.10.3343/alm.2013.33.5.309CrossRefGoogle ScholarPubMed
Smith, SC, Ladenson, JH, Mason, JW, Jaffe, AS. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 1997; 95: 163168.10.1161/01.CIR.95.1.163CrossRefGoogle ScholarPubMed
Soongswang, J, Durongpisitkul, K, Nana, A, et al. Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children. Pediatr Cardiol 2005; 26: 4549.10.1007/s00246-004-0677-6CrossRefGoogle ScholarPubMed
Al-Biltagi, M, Issa, M, Hagar, HA, Abdel-Hafez, M, Aziz, NA. Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis. Acta Paediatr 2010; 99: 15101516.10.1111/j.1651-2227.2010.01882.xCrossRefGoogle ScholarPubMed
Kobayashi, D, Aggarwal, S, Kheiwa, A, Shah, N. Myopericarditis in children: elevated troponin I level does not predict outcome. Pediatr Cardiol. 2012; 33: 10401045.10.1007/s00246-012-0222-yCrossRefGoogle Scholar
Sachdeva, S, Song, X, Dham, N, Heath, DM, DeBiasi, RL. Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis. Am J Cardiol. 2015; 115: 499504.10.1016/j.amjcard.2014.11.029CrossRefGoogle ScholarPubMed
Freixa, X, Sionis, A, Castel, Á., et al. Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis. Transplant Proc. 2009; 41: 22342236.10.1016/j.transproceed.2009.06.012CrossRefGoogle ScholarPubMed
Caforio, AL P, Marcolongo, R, Basso, C, Iliceto, S. Clinical presentation and diagnosis of myocarditis. Heart 2015; 0: 113.Google Scholar
Imazio, M. Trinchero Triage and management of acute pericarditis. Int J Cardiol 2007; 118: 286294.10.1016/j.ijcard.2006.07.100CrossRefGoogle ScholarPubMed
Han-Ping, W, Mao-Jen, L, Wen-Chieh, Y, Kang-His, W, Chun-Yu, C. Predictors of extracorporeal membrane oxygenation support for children with acute myocarditis. Biomed Res Int 2017, 18.Google Scholar
Duo, X, Ruo-Chi, Z, Wen-Hui, G, Han-Bin, C. A risk prediction model for in-hospital mortality in patients with suspected myocarditis. Chin Med J 2017; 130: 782790.Google Scholar
Buttu, A, Rossano, JW, Nandi, D, et al. Elevated troponin in the first 72 h of hospitalization for pediatric viral myocarditis is associated with ECMO: an analyses of the PHIS+ DAtabase. Pediatr Cardiol 2018; 39: 11391143.10.1007/s00246-018-1871-2CrossRefGoogle Scholar